SUNDAY, SEPTEMBER 25, 2016

UOSSM appeals for urgent mass immunization for Syrian children against measles

The Union of Syrian Medical Relief Organizations appealed to the U.N. Children's Fund and the World Health Organization on Thursday for a mass measles immunization program for Syrian children. Read More »

ACIP updates pneumococcal conjugate vaccine recommendations

The Advisory Committee on Immunization Practices recently updated its recommendations on using 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine with immunocompromised children, the Centers for Disease Control and Prevention said on Friday. Read More »

CDC gives updated guidelines for handling H5N1 influenza virus

H5N1 Read More »

New study provides insight into anti HRV drug development

Scientist Angus MacLeod and his colleagues reported last week that progress has been made in the search for the first effective vaccine against human rhinoviruses. Read More »

Cell biologist to start work on structure of malaria parasite genome

Malaria Read More »

Legislation to make four-strain flu vaccine available passes House

Flu vaccine Read More »

Indiana health officials ask people to protect themselves from swine flu

Swine flu Read More »

Clinical trial of type-1 diabetes vaccine conducted by Stanford researchers

A clinical trial of a vaccine designed to combat type-1 diabetes was recently conducted by researchers at the Stanford University School of Medicine and showed promising results in the fight against the disease. Read More »

England offers vaccine for infants against rotavirus

Rotavirus Read More »

TSRI scientists make RNA discovery that could impact vaccine development

A recent RNA discovery by a team of scientists at the La Jolla, California-based The Scripps Research Institute could result in medical applications like improved viral vaccines and treatments for autoimmune conditions. Read More »

Republic of Sudan denies vaccinations to children

The Republic of Sudan, which is headed by President Omar al-Bashir, rejected a proposition on Sunday that would have allowed humanitarian efforts to carry out a vaccination campaign for children. Read More »

UNAIDS expresses commitment to eradicate HIV/AIDS

The Board of the Joint United Nations Programme on HIV/AIDS announced on Monday at its 32nd meeting that it is committed to achieving the Millennium Development Goals and a world free of HIV/AIDS. Read More »

NanoViricides submits letter of intent to file drug application with EMA

Dengue fever Read More »

Kenya signals partnership with UNAIDS, Global Fund

The leaders of the Joint U.N. Program on HIV/AIDS, the Global Fund to Fight AIDS, Tuberculosis and Malaria and Kenya's government recently met in Nairobi to discuss the fight against deadly diseases. Read More »

Medicago and Immune Design announce vaccine development partnership

Immune Design and Medicago, Inc., announced on Thursday that have agreed to a license agreement that will allow Medicago to use Immune Design's Toll-like Receptor 4 agonist, Glucopyranosyl Lipid A. Read More »

Soligenix reports successful clinical trial of pediatric Crohn's disease drug

Soligenix, Inc., announced on Friday a successful clinical trial during the Phase 1 Study BDP-PCD-01, the first clinical study to test SGX203, a drug for the treatment of pediatric Crohn's disease. Read More »

Central American and Caribbean countries rally to eliminate malaria

The Global Fund to Fight AIDS, Tuberculosis and Malaria announced on Friday that ten countries in Central America and the Caribbean joined a regional initiative with the goal of eliminating malaria by 2020. Read More »

Southern Illinois reports first positive West Nile virus mosquitoes in 2013

The Illinois Department of Health confirmed the first batches last week of West Nile virus positive mosquitoes were reported in southern Illinois. Read More »

Researchers find new method of detecting dengue virus

Dengue fever Read More »

New vaccine shows promise for advanced melanoma treatment

A new vaccine developed by researchers at the Roswell Park Cancer Institute may successfully treat stage III and stage IV melanoma, one of the top six cancers diagnosed in America. Read More »